Marcus Ford, MD
Adult Reconstructive Orthopaedic Surgery · Fort Worth, TXNPI 1790075323
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $257,283 of the $296,031 with a category attached, or 86.9%. Medacta USA, Inc. accounts for 66.8% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $112,026, more than ten times the $4,345 reported in 2019. Among adult reconstructive orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 342 payments — averaging $865.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$198K
- Zimmer Biomet$38K
- Medical Device Business Services, Inc.$29K
- Osteoremedies, LLC$12K
- Microport Orthopedics Inc$6K
- Depuy Synthes Products, Inc.$6K
- plus $6K from 5 others
Across 19 payments — averaging $5523.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$105K
What the payments were for
- Consulting fees$257,28387%
- Speaking & faculty fees$5,0002%
- Travel & lodging$24,5768%
- Food & beverage$9,1713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 175 | $197,667 |
| Zimmer Biomet | 49 | $38,354 |
| Medical Device Business Services, Inc. | 33 | $29,379 |
| Osteoremedies, LLC | 19 | $12,273 |
| Microport Orthopedics Inc | 20 | $6,478 |
| Depuy Synthes Products, Inc. | 5 | $6,004 |
| Smith+Nephew | 13 | $3,898 |
| Johnson & Johnson | 24 | $1,854 |
| Stryker | 2 | $61 |
| Avanos Medical | 1 | $41 |
| Kerecis Limited | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$95,265
- GMK Sphere Revision System$71,112
- ACTIS$33,649
- ROSA$20,123
- AMISTEM$16,506
- ORTHOPEDICS$7,625
- AMIStem H Femoral Stems$6,257
- MPO Medial Pivot Knee$6,061
- Journey II$3,726
- Persona$2,458
- REDAPT Revision Hip System$2,243
- ATTUNE$1,614
- Remedy Spacer$1,500
- Anthem$1,200
- Legion$1,200
- Remedy Spectrum GV Spacer$833
- NextAR Knee$555
- SPHERIKA$508
- Velys$364
- NEXT AR$337
How this compares
$296,031 in reported general payments places this provider in the 90th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 159 | $2,856 |
| Cephalexin | 14 | $1,975 |
| Tranexamic Acid | 51 | $1,056 |
| Methylprednisolone | 132 | $961 |
| Mupirocin | 109 | $879 |
| Cefaclor | 43 | $704 |
| Ciprofloxacin Hcl | 12 | $545 |
| Minocycline Hcl | 12 | $370 |
| Meloxicam | 129 | $282 |
| Oxycodone Hcl | 44 | $206 |
| Prednisone | 28 | $202 |
| Ondansetron OdtOndansetron | 43 | $192 |
| Diclofenac Sodium | 17 | $144 |
| Tramadol Hcl | 41 | $140 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 63 | $131 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Fort Worth
- Steven WeedenFort Worth$370K
- Steven OgdenFort Worth$36K
- Gurpreet BajajFort Worth$27K
- Joel DennisonFort Worth$13K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$3.8M
- John BarringtonPlano$2.2M
- Roger EmersonPlano$691K
- Donald HohmanDallas$537K
- Raul MarquezEdinburg$278K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.